Zhu 2012a.
Methods | Randomised clinical trial, China | |
Participants | 97 hospitalised adults admitted with stroke, at nutritional risk due to stroke Male:Female = 56:41 Mean age = 72 years Exclusion criteria: None |
|
Interventions | Experimental group 1: Received both enteral and parenteral supplements.The energy was 84 ‐ 105 kj/kg/day, and increased to the target volume 126 ‐ 147 kj/kg/day, based on participant's recovery condition. Whole protein supplements (6.3 kJ/ml) were given through nasogastric tube, and the sugar, fat and protein were provided through vein tube.(n = 33) Experimental group 2: Received only enteral supplements. The energy was 84 ‐ 105 kj/kg/day, and increased to the target volume 126 ‐ 147 kj/kg/day based on participant's recovery condition. All the nutrition was provided through the nasogastric tube. (n = 32) Control group: The nutrition (6.3 kJ/ml)was given through nasogastric tube under the control of a specialist nurse(n = 32) |
|
Outcomes | Triceps skinfold thickness, arm muscle circumference, haemoglobin, albumin, prealbumin, triglyceride, incidence rate of malnutrition; infection rate, mortality, NIHSS, Barthel Index | |
Study dates | Not stated | |
Notes | Same as Zhu 2012b, but with experimental group 1 vs control group. We found no contact information for the authors. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Not described |
Allocation concealment (selection bias) | Unclear risk | Not described |
Blinding of participants and personnel (performance bias) All outcomes | High risk | The participants and personnel were not blinded. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not described |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | The number of participants with incomplete data was not reported. |
Selective reporting (reporting bias) | Low risk | No protocol could be obtained but the trial did report on all‐cause mortality and serious adverse events. |
For‐profit bias | Unclear risk | It was unclear how the trial was funded. |
Other bias | Low risk | The trial appeared to be free of other components that could put it at risk of bias. |